Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.9 USD | -2.13% | -0.80% | +23.50% |
29/05 | BofA Securities Adjusts Crane Price Target to $165 From $140, Maintains Buy Rating | MT |
27/05 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.50% | 833.93Cr | |
+11.06% | 1.57TCr | |
-20.27% | 1.2TCr | |
-7.75% | 641.38Cr | |
+43.00% | 208.1Cr | |
+5.49% | 158.82Cr | |
+7.53% | 90Cr | |
+17.13% | 90Cr | |
-5.14% | 65Cr | |
-12.61% | 62Cr |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- UBS Raises Crane's Price Target to $152 From $120, Maintains Neutral Rating